Companies / Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc.
Nasdaq: MGXCIK 1785279EMERYVILLE, CA
Financials · FY2025
Ownership
37.8M shares outstanding · as of Aug 6, 2026
Ownership
| Insiders | 1.68% | 635,694 |
| Institutions | 19.06% | 7,200,256 |
| Public float | 79.26% | 29,941,155 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Irish JianCEOChief Executive Officer · Director | 0.88% | 333,770 |
Wapnick PamelaChief Financial Officer | 0.50% | 187,375 |
Wein MatthewSee Remarks | 0.30% | 114,549 |
Bjerkholt EricDirector | — | — |
Dere Willard HDirector | — | — |
Institutional holders 57
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.06M | 3.36% | |
| $1.06M | 2.09% | |
| $857.0K | 1.40% | |
| $806.2K | 1.32% | |
| $702.9K | 1.15% | |
| $665.7K | 1.31% | |
| $530.4K | 1.05% | |
| $480.2K | 0.95% | |
| $428.3K | 0.70% | |
| $343.1K | 0.67% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2025 as of | Norges Bank 13F manager | Exit | Common Stock | $-343.1K | -252K -100.00% | 0 | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common Stock | $213.7K | +160K +25.38% | 787,900 2.09% of shares | low |
| Q4 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $122.0K | +34K +388.40% | 42,481 0.11% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common Stock | $-87.2K | -65K -27.67% | 170,104 0.45% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common Stock | $74.2K | +55K +12.55% | 496,767 1.31% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $70.1K | +52K +17.09% | 358,200 0.95% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Trim | Common Stock | $-69.2K | -52K -65.22% | 27,521 0.07% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | Exit | Common Stock | $-54.9K | -34K -100.00% | 0 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| MGX | Common Stock | 59102M104 |